Reports
Reports
Sale
The global peptide synthesis market size was valued at USD 513.86 million in 2023, driven by the increased emphasis on personalized medicine across the globe. The market size is anticipated to grow at a CAGR of 8.8% during the forecast period of 2024-2032 to achieve a value of USD 1,097.76 million by 2032.
Peptide synthesis is a known laboratory technique which is used to generate peptides. Peptides are small chains of amino acids that are connected together with the peptide bonds. Peptides play a significant role in several fields, including medicine, biotechnology, and research. They can be used as therapeutic agents, diagnostic tools, or molecular probes for studying biological processes. In peptide synthesis, amino acids are put together in a unique sequence with the help of a step-by-step assembly technique to form the desired peptide. There are two primary methods of performing peptide synthesis: solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS).
Overall, peptide synthesis is a versatile technique that enables the creation of custom-designed peptides with specific amino acid sequences. It allows researchers and scientists to generate peptides for various applications, including drug development, biomarker discovery, and understanding protein structure-function relationships.
The market for peptide synthesis is influenced by several trends, including the increased emphasis on peptide libraries and screening. The rising demand for long and difficult peptides is growing, including cyclic peptides, stapled peptides, and peptide conjugates. These peptides offer unique properties and enhanced stability, making them attractive for drug development and research applications.
Additionally, peptide-based therapeutics are continuously being explored for the treatment of rare genetic diseases as targeting specific peptides can potentially correct or modulate genetic defects. The development of peptide therapies for rare diseases is gaining momentum, which is driven by the advancements in gene editing technologies and personalized medicine approaches. Researchers are increasingly incorporating non-natural amino acids into peptide sequences to enhance their stability, bioactivity, and pharmacokinetic properties. This allows the development of peptide-based therapeutics with improved drug-like characteristics, expanding the potential applications of peptides in drug discovery and delivery. Outsourcing peptide synthesis to contract manufacturing organizations (CMOs) is becoming a popular trend among pharmaceutical and biotech companies, which is leading to higher peptide synthesis market demand. This trend allows companies to focus on their core competencies while accessing high-quality peptides for their drug development pipelines.
Automation and robotics are also being increasingly employed in peptide synthesis processes that enables high-throughput and efficient production. Automated peptide synthesizers and robotic systems facilitate precise control, rapid synthesis, and reduced human error, thereby enhancing the scalability and reproducibility of peptide manufacturing.
Market Breakup by Technology
Market Breakup by Products
Peptide Synthesis Market by End User
Market Breakup by Region
The market for peptide synthesis has been witnessing steady growth and is anticipated to witness significant growth in the coming years as well. The market growth is primarily driven by the increasing demand for therapeutics. Due to their exclusivity, potency, and low toxicity in comparison to traditional small molecule drugs, the demand for peptide-based therapeutics in regard with various diseases, such as cancer, diabetes, and cardiovascular disorders, is increasing and directly contributing to the global peptide synthesis market growth.
Additionally, the increasing number of ongoing advancements in peptide research, including understanding the structure-activity relationships and developing new synthesis techniques, are collectively contributing to the possibilities for the introduction of peptide-based therapeutics in the market with multiple benefits, propelling the demand for peptide synthesis technologies and services in the market.
The increasing emphasis on personalized medicine and targeted therapies has increased the demand for customized peptides in the market. Peptide synthesis enables the creation of peptides with unique sequences and modifications tailored to individual patient needs, leading to the development of personalized treatments. The rising availability of customisation as per the requirement is also contributing to the peptide synthesis market share. Peptides find applications in various fields, including biotechnology, life sciences, and diagnostics. Peptides are also used as tools for comprehending protein-protein interactions, as diagnostic biomarkers, and in the development of peptide-based vaccines. The expanding applications of peptides across these industries aid the growth of the peptide synthesis market.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Technology |
|
Breakup by Products |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Peptide Synthesis Market Overview
3.1 Global Peptide Synthesis Market Historical Value (2017-2023)
3.2 Global Peptide Synthesis Market Forecast Value (2024-2032)
4 Global Peptide Synthesis Market Landscape
4.1 Global Enteric Disease Testing: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Enteric Disease Testing: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Peptide Synthesis Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Peptide Synthesis Market Segmentation
6.1 Global Peptide Synthesis Market by Technology
6.1.1 Solid-Phase
6.1.2 Liquid-Phase
6.1.3 Hybrid
6.1.4 Recombinant
6.2 Global Peptide Synthesis Market by Products
6.2.1 Market Overview
6.2.2 Equipment
6.2.3 Reagents
6.2.4 Consumables
6.2.5 Other Product
6.3 Global Peptide Synthesis Market by End User
6.3.1 Market Overview
6.3.2 Pharmaceutical and Biotechnology Companies
6.3.3 Contract Development and Manufacturing Organization (CDMO)
6.3.4 Academic and Research Institutes
6.4 Global Peptide Synthesis Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Peptide Synthesis Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Peptide Synthesis Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Peptide Synthesis Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Peptide Synthesis Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Peptide Synthesis Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 AAPPTec
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Anaspec
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Bachem Holding AG
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Biotage
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 CSBio Company Inc.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 CEM Corporation
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Gyros Protein Technologies AB
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Merck KGaA
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Biosynth Carbosynth (Vivitide)
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Thermo Fisher Scientific
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 513.86 million in 2023, driven by the increasing peptide research.
The market is anticipated to grow at a CAGR of 8.8% during the forecast period of 2024-2032 and reach a market value of USD 1,097.76 million by 2032.
The exclusivity, potency, and low toxicity of peptide-based therapeutics in comparison to traditional small molecule drugs has increased the demand for peptide synthesis in the market as they are beneficial in various diseases, such as cancer, diabetes, and cardiovascular disorders.
The increasing use of automation and robots in the process of peptide synthesis is among the major key trends influencing the market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The products in the market include equipment, reagents, consumables, among others.
Technologies available in the market include solid-phase, liquid-phas, hybrid, recombinant.
The end users in the market include pharmaceutical & biotechnology companies, contract development and manufacturing organization (CDMO), academic and research institutes.
Key players involved in the market are AAPPTec, Anaspec, Bachem Holding AG, Biotage, CSBio Company Inc., CEM Corporation, Gyros Protein Technologies AB, Merck KGaA, Biosynth Carbosynth (Vivitide), and Thermo Fisher Scientific.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.